{
     "PMID": "28476642",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170905",
     "LR": "20170906",
     "IS": "1873-7064 (Electronic) 0028-3908 (Linking)",
     "VI": "121",
     "DP": "2017 Jul 15",
     "TI": "Properties of the corticostriatal long term depression induced by medial prefrontal cortex high frequency stimulation in vivo.",
     "PG": "278-286",
     "LID": "S0028-3908(17)30197-1 [pii] 10.1016/j.neuropharm.2017.05.001 [doi]",
     "AB": "Repetitive stimulation of cognitive forebrain circuits at frequencies capable of inducing corticostriatal long term plasticity is increasingly being used with therapeutic purposes in patients with neuropsychiatric disorders. However, corticostriatal plasticity is rarely studied in the intact brain. Our aim was to study the mechanisms of corticostriatal long term depression (LTD) induced by high frequency stimulation (HFS) of the medial prefrontal cortex in vivo. Our main finding is that the LTD induced in the dorsomedial striatum by medial prefrontal cortex HFS in vivo (prefrontostriatal LTD) is not affected by manipulations that block or reduce the LTD induced in the dorsolateral striatum by motor cortex HFS in brain slices, including pharmacological dopamine receptor and CB1 receptor blockade, chronic nigrostriatal dopamine depletion, CB1 receptor genetic deletion and selective striatal cholinergic interneuron (SCIN) ablation. Conversely, like in the hippocampus and other brain areas, prefrontostriatal LTD is NMDA receptor dependent. Thus, we describe a novel form of corticostriatal LTD that operates in brain circuits involved in reward and cognition and could be relevant for understanding the therapeutic effects of deep brain stimulation.",
     "CI": [
          "Copyright (c) 2017 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Braz, Barbara Y",
          "Belforte, Juan E",
          "Murer, M Gustavo",
          "Galinanes, Gregorio L"
     ],
     "AU": [
          "Braz BY",
          "Belforte JE",
          "Murer MG",
          "Galinanes GL"
     ],
     "AD": "Universidad de Buenos Aires, Facultad de Medicina, Departamento de Ciencias Fisiologicas, Grupo de Neurociencia de Sistemas, Buenos Aires, Argentina; Universidad de Buenos Aires, CONICET, Instituto de Fisiologia y Biofisica (IFIBIO) Houssay, Buenos Aires, Argentina. Electronic address: barbybraz@gmail.com. Universidad de Buenos Aires, Facultad de Medicina, Departamento de Ciencias Fisiologicas, Grupo de Neurociencia de Sistemas, Buenos Aires, Argentina; Universidad de Buenos Aires, CONICET, Instituto de Fisiologia y Biofisica (IFIBIO) Houssay, Buenos Aires, Argentina. Electronic address: belfortej@yahoo.com. Universidad de Buenos Aires, Facultad de Medicina, Departamento de Ciencias Fisiologicas, Grupo de Neurociencia de Sistemas, Buenos Aires, Argentina; Universidad de Buenos Aires, CONICET, Instituto de Fisiologia y Biofisica (IFIBIO) Houssay, Buenos Aires, Argentina. Electronic address: gmurer@fmed.uba.ar. Universidad de Buenos Aires, Facultad de Medicina, Departamento de Ciencias Fisiologicas, Grupo de Neurociencia de Sistemas, Buenos Aires, Argentina; Universidad de Buenos Aires, CONICET, Instituto de Fisiologia y Biofisica (IFIBIO) Houssay, Buenos Aires, Argentina. Electronic address: gregorio.galinanes@unige.ch.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170502",
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (Adrenergic Agents)",
          "0 (Benzazepines)",
          "0 (Dopamine Antagonists)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Heparin-binding EGF-like Growth Factor)",
          "0 (Piperidines)",
          "0 (Pyrazoles)",
          "0 (Receptor, Cannabinoid, CB1)",
          "0 (SCH 23390)",
          "3I4FA44MAI (AM 251)",
          "6LR8C1B66Q (Dizocilpine Maleate)",
          "8HW4YBZ748 (Oxidopamine)",
          "EC 1.14.16.2 (Tyrosine 3-Monooxygenase)",
          "EC 2.3.1.6 (Choline O-Acetyltransferase)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic Agents/toxicity",
          "Animals",
          "Animals, Newborn",
          "Benzazepines/pharmacology",
          "Choline O-Acetyltransferase/genetics/metabolism",
          "Corpus Striatum/*cytology/injuries/*physiology",
          "Dizocilpine Maleate/pharmacology",
          "Dopamine Antagonists/pharmacology",
          "Excitatory Amino Acid Antagonists/pharmacology",
          "Heparin-binding EGF-like Growth Factor/genetics/metabolism",
          "Long-Term Synaptic Depression/drug effects/genetics/*physiology",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Transgenic",
          "Neural Pathways/physiology",
          "Neurons/drug effects/*physiology",
          "Oxidopamine/toxicity",
          "Piperidines/pharmacology",
          "Prefrontal Cortex/*physiology",
          "Pyrazoles/pharmacology",
          "Receptor, Cannabinoid, CB1/antagonists & inhibitors/genetics/metabolism",
          "Tyrosine 3-Monooxygenase/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Corticostriatal plasticity",
          "Dopamine",
          "Endocannabinoids",
          "Long term depression",
          "NMDA receptor",
          "Prefrontal cortex",
          "Striatum"
     ],
     "EDAT": "2017/05/10 06:00",
     "MHDA": "2017/09/07 06:00",
     "CRDT": [
          "2017/05/07 06:00"
     ],
     "PHST": [
          "2017/01/06 00:00 [received]",
          "2017/04/24 00:00 [revised]",
          "2017/05/01 00:00 [accepted]",
          "2017/05/10 06:00 [pubmed]",
          "2017/09/07 06:00 [medline]",
          "2017/05/07 06:00 [entrez]"
     ],
     "AID": [
          "S0028-3908(17)30197-1 [pii]",
          "10.1016/j.neuropharm.2017.05.001 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 2017 Jul 15;121:278-286. doi: 10.1016/j.neuropharm.2017.05.001. Epub 2017 May 2.",
     "term": "hippocampus"
}